Rapid Micro Biosystems (RPID) Net Cash Flow Growth (5y) (2025 - 2026)

Rapid Micro Biosystems (RPID) Net Cash Flow Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.44 Bn	193.84 Bn	7.27 Bn
2	Stryker	127.32 Bn	123.85 Bn	4.50 Bn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn
5	Edwards Lifesciences	51.90 Bn	47.65 Bn	1.35 Bn
6	Dexcom	34.30 Bn	32.36 Bn	830.00 Mn
7	GE HealthCare Technologies	33.74 Bn	31.63 Bn	2.18 Bn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn
10	Rapid Micro Biosystems	80.50 Mn	60.73 Mn	1.21 Mn

Download Data